Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biomarker
Marketing
Evidence pushes back on FDA's use of surrogate markers: report
A recent report shows that there is little evidence backing the FDA's use of surrogate markers to determine if a medicine is fit for approval.
Kevin Dunleavy
May 29, 2024 11:25am
Pharma-backed group wants patients to test their biomarkers
Feb 5, 2024 7:25am
Eli Lilly's Retevmo gets FDA nod to treat all RET cancer types
Sep 22, 2022 11:15am
Michael Landon’s daughter urges testing in pancreatic cancer PSA
Nov 8, 2021 7:35am
Guardant nabs chief commercial officer from Gilead
Jul 13, 2021 9:05am
Genentech oncology exec moves to Guardant to boost diagnostics
May 24, 2021 9:11am
